Pharos Capital Invests in Sanderling Renal Services
May 16, 2022
Pharos Capital Group made a significant growth investment in Sanderling Renal Services to support expansion of the company's home dialysis operations, telemedicine and hospital eDialysis contracts, and geographic growth via acquisitions and de novo clinics. Sanderling, headquartered in Nashville, Tennessee, operates 14 clinics across six states and provides tele-nephrology and acute eDialysis services to 30+ partner hospitals; terms were not disclosed.
- Buyers
- Pharos Capital Group, LLC
- Targets
- Sanderling Renal Services, Inc.
- Industry
- Healthcare Services
- Location
- Tennessee, United States
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.